Sonoma Pharmaceuticals (SNOA) Free Cash Flow (2010 - 2025)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Free Cash Flow of -$811000.0 in Q4 2025, down 25.74% quarter-over-quarter from -$645000.0 in Q3 2025, and down 244.05% on a YoY basis from $563000.0 in Q4 2024.
Sonoma Pharmaceuticals (SNOA) Free Cash Flow (2010 - 2025) Analysis & Trends
Sonoma Pharmaceuticals' Free Cash Flow history runs 16 years deep, the most recent figure standing at -$811000.0 for Q4 2025.
- In Q4 2025, Free Cash Flow fell 244.05% year-over-year to -$811000.0; the TTM figure through Dec 2025 stood at -$3.7 million (down 2682.64% YoY), while the FY2025 annual figure was -$168000.0, up 93.0% from the prior year.
- Free Cash Flow was -$811000.0 for Q4 2025 at Sonoma Pharmaceuticals, down from -$645000.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $563000.0 in Q4 2024 to a low of -$2.6 million in Q1 2023.
- Historically, Free Cash Flow has averaged -$921600.0 across 5 years, with a median of -$1.0 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Free Cash Flow jumped 150.95% in 2024, then tumbled 296.65% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$327000.0 in 2021, then decreased by 15.9% to -$379000.0 in 2022, then sank by 191.56% to -$1.1 million in 2023, then surged by 150.95% to $563000.0 in 2024, then plunged by 244.05% to -$811000.0 in 2025.
- The last three Free Cash Flow figures came in at -$811000.0 (Q4 2025), -$645000.0 (Q3 2025), and -$2.1 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn | -811,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -811,000.00 |
| Dec 31, 2025 | -811,000.00 |
| Sep 30, 2025 | -645,000.00 |
| Sep 30, 2025 | -645,000.00 |
| Jun 30, 2025 | -2.12 Mn |
| Jun 30, 2025 | -2.12 Mn |
| Mar 31, 2025 | -142,000.00 |
| Mar 31, 2025 | -142,000.00 |
| Dec 31, 2024 | 563,000.00 |
| Dec 31, 2024 | 563,000.00 |
| Sep 30, 2024 | 328,000.00 |
| Sep 30, 2024 | 328,000.00 |
| Jun 30, 2024 | -917,000.00 |
| Jun 30, 2024 | -917,000.00 |
| Mar 31, 2024 | 170,000.00 |
| Mar 31, 2024 | 170,000.00 |
| Dec 31, 2023 | -1.11 Mn |
| Dec 31, 2023 | -1.11 Mn |
| Sep 30, 2023 | -1.23 Mn |
| Sep 30, 2023 | -1.23 Mn |